Valérie Pécresse, Minister of Higher Education and Research
What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart…
Address: 14 ave Duquesne, 75007 Paris,France
Tel: 01 40 56 60 65
Web: http://www.sante.gouv.fr/
The Committee Economic Health Products (CEPS) replaced the previous Economic Committee of drugs in 2000. Its missions have been extended to cover health products and services associated with refundable in addition to drugs and it has been amended accordingly.
CEPS contributes to the development of drug policy by putting into practice advice it receives from relevant ministers, applying it notably to price fixing with respect to expenditure and financial regulation of the market. In order to carry this out, the CEPS reaches agreements with businesses on relevant topics, such as drug prices, price evolution, drug reimbursements, regulations concerning the proper use of drugs and sales volumes, as well as methods of participation of enterprises in the implementation of departmental policies.
What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart…
What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart…
Can you highlight some of the more recent milestones for Stallergenes? Stallergenes has been successful over recent years for several reasons, the first of which is the growth of the…
As Quintiles is present in all major pharmaceutical markets worldwide, what’s the relevance of the French affiliate and what role it plays inside such a globalized organization? France is important…
When we met your Italian colleague, he noted that they had tripled their turnover in a five year period. You haven’t done badly yourself in the relatively short period of…
Biogaran was an initiative from Servier in the mid 1990s before there was even a generic pharmaceutical market in France. Could you speak of your history and of the origins…
Janssen-Cilag is involved in not only selling its products in France but research and production as well. As France is a leading subsidiary, can you speak to the importance of…
Endotis was incorporated in 2003 on the basis of a technology transfer from on a French public research institution. Can you elaborate on the origins? The group was founded from…
This interview was conducted with Jacques de Chilly and Theirry de Lumley of Aderly hereafter referred to as J.C. and T.L. respectively. Aderly was founded in 1974 in order to…
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
CIP and GERS have very unique relationships with the pharmaceutical industry. Could you elaborate on the role of these two bodies? Club Inter-pharmaceutique (CIP) is a professional association created in…
As a majority of our readers are American that may be used to a different model of clusters can you explain the unique characteristics of the pôles de compétitivité? The…
See our Cookie Privacy Policy Here